MIF and systemic sclerosis: Serum MIF was significantly increased in SSc patients receiving angiotensin II receptor blockers or beta blockers, while not in those with a diagnosis of systemic hypertension (Supplementary tables 3 and 5), a finding confirmed in multivariable analysis after adjusting for the presence of systemic hypertension and low FVC (Table 2).